US$ 22.40
ghk cu clinical trial injection humans ghk-cu human GHK-Cu Peptide GHK-Cu Peptide Injection: Clinical Considerations
Description
(2002) observed an antimutagenic effect of epithalon when administered to senescence-accelerated mice

(PubMed) Badawy AA

There is a growing body of research on BPC-157 and Thymosin Beta 4, but long-term studies and large-scale clinical trials are still lacking

Similar findings have been made in animals with pituitary dwarfism, known to have low levels of circulating thymulin
